Glucagon-Like Peptide-1 Agonist (GLP-1)

Glucagon-Like Peptide-1 Agonists (GLP-1) are compounds that mimic the incretin hormone GLP-1, which enhances insulin secretion and inhibits glucagon release, thereby improving blood glucose control. They are primarily used in the management of type 2 diabetes and have shown potential in weight management and cardiovascular health, making them relevant for longevity and health optimization.